The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Image in cardiology

Percutaneous treatment of paravalvular leaks after transcatheter aortic valve implantation with the CoreValve self-expanding bioprosthesis

EuroIntervention 2013;9:292. DOI: 10.4244/EIJV9I2A47

Institute of Cardiology, University of Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy
Mild-to-moderate aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) is common and often clinically silent. Higher-degree AR may occur, with significant haemodynamic and clinical consequences. Treatment of this condition is challenging and there are no evidence-based therapeutic options. This image illustrates the successful percutaneous management of clinically relevant paravalvular leaks (PVL) after implantation of the CoreValve bioprosthesis (Medtronic, Minneapolis, MN, USA) with the use of vascular plug devices.

Conflict of interest statement

The authors report no financial relationships or conflicts of interest regarding the content herein.



Figure 1. Examples of successful percutaneous closure of severe paravalvular ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
The utility of stent enhancement to guide percutaneous coronary intervention for bifurcation lesions